627 related articles for article (PubMed ID: 30497814)
1. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
Ramos MFKP; Pereira MA; Dias AR; Yagi OK; Zaidan EP; Ribeiro-Júnior U; Zilberstein B; Cecconello I
Eur J Surg Oncol; 2019 Mar; 45(3):460-465. PubMed ID: 30497814
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer.
Danielson H; Kokkola A; Kiviluoto T; Sirén J; Louhimo J; Kivilaakso E; Puolakkainen P
Scand J Surg; 2007; 96(1):35-40. PubMed ID: 17461310
[TBL] [Abstract][Full Text] [Related]
3. Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study.
Rausei S; Ruspi L; Rosa F; Morgagni P; Marrelli D; Cossu A; Cananzi FC; Lomonaco R; Coniglio A; Biondi A; Cipollari C; Graziosi L; Fumagalli U; Casella F; Bertoli P; di Leo A; Alfieri S; Vittimberga G; Roviello F; Orsenigo E; Quagliuolo V; Montemurro S; Baiocchi G; Persiani R; Bencivenga M; Donini A; Rosati R; Sansonetti A; Ansaloni L; Zanoni A; Galli F; Dionigi G;
Eur J Surg Oncol; 2016 Dec; 42(12):1881-1889. PubMed ID: 27266816
[TBL] [Abstract][Full Text] [Related]
4. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma.
Memon MA; Subramanya MS; Khan S; Hossain MB; Osland E; Memon B
Ann Surg; 2011 May; 253(5):900-11. PubMed ID: 21394009
[TBL] [Abstract][Full Text] [Related]
6. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
7. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
[TBL] [Abstract][Full Text] [Related]
8. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
[TBL] [Abstract][Full Text] [Related]
9. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
[TBL] [Abstract][Full Text] [Related]
10. Gastric cancer: Current status of lymph node dissection.
Degiuli M; De Manzoni G; Di Leo A; D'Ugo D; Galasso E; Marrelli D; Petrioli R; Polom K; Roviello F; Santullo F; Morino M
World J Gastroenterol; 2016 Mar; 22(10):2875-93. PubMed ID: 26973384
[TBL] [Abstract][Full Text] [Related]
11. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
Lu W; Zeng X; Li N; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
[TBL] [Abstract][Full Text] [Related]
12. Survival benefit of extended D2 resection for proximal gastric cancer.
Volpe CM; Driscoll DL; Miloro SM; Douglass HO
J Surg Oncol; 1997 Mar; 64(3):231-6. PubMed ID: 9121155
[TBL] [Abstract][Full Text] [Related]
13. Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis.
Galizia G; Lieto E; De Vita F; Castellano P; Ferraraccio F; Zamboli A; Mabilia A; Auricchio A; De Sena G; De Stefano L; Cardella F; Barbarisi A; Orditura M
Surgery; 2015 Feb; 157(2):285-96. PubMed ID: 25532433
[TBL] [Abstract][Full Text] [Related]
14. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative.
Randle RW; Swords DS; Levine EA; Fino NF; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Pawlik TM; Jin LX; Spolverato G; Schmidt C; Worhunsky D; Cho CS; Maithel SK; Votanopoulos KI
J Surg Oncol; 2016 Jun; 113(7):750-5. PubMed ID: 26996496
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the operative outcomes of D1 and D2 gastrectomy performed at a single Western center with multiple surgeons: a retrospective analysis with propensity score matching.
Lam S; Tan E; Menezes A; Martin D; Gallagher J; Storey D; Sandroussi C
World J Surg Oncol; 2018 Jul; 16(1):136. PubMed ID: 29986713
[TBL] [Abstract][Full Text] [Related]
16. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302
[TBL] [Abstract][Full Text] [Related]
17. The Turkish experience with curative gastrectomies for gastric carcinoma: is D2 dissection worthwhile?
Yildirim E; Celen O; Berberoglu U
J Am Coll Surg; 2001 Jan; 192(1):25-37. PubMed ID: 11192920
[TBL] [Abstract][Full Text] [Related]
18. Oncologic feasibility of D1+ gastrectomy for patients with cT1N1, cT2N0-1, or cT3N0 gastric cancer.
Kota I; Makoto H; Satoshi K; Yutaka T; Etsuro B; Masanori T
Eur J Surg Oncol; 2021 Feb; 47(2):456-462. PubMed ID: 32919813
[TBL] [Abstract][Full Text] [Related]
19. D2 lymph node dissection improves staging in patients with gastric adenocarcinoma.
Putchakayala K; Difronzo LA
Am Surg; 2011 Oct; 77(10):1326-9. PubMed ID: 22127080
[TBL] [Abstract][Full Text] [Related]
20. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
